AAC (AAC) Getting Somewhat Positive News Coverage, Study Shows

Headlines about AAC (NYSE:AAC) have been trending somewhat positive recently, Accern Sentiment Analysis reports. Accern ranks the sentiment of media coverage by monitoring more than 20 million blog and news sources in real time. Accern ranks coverage of public companies on a scale of -1 to 1, with scores closest to one being the most favorable. AAC earned a news sentiment score of 0.04 on Accern’s scale. Accern also gave media coverage about the company an impact score of 45.8638247529777 out of 100, indicating that recent media coverage is somewhat unlikely to have an effect on the stock’s share price in the next several days.

Shares of AAC (AAC) traded down $0.03 during trading hours on Friday, hitting $9.27. 95,995 shares of the stock traded hands, compared to its average volume of 130,042. The firm has a market capitalization of $223.19, a P/E ratio of -154.50 and a beta of 1.95. The company has a quick ratio of 3.28, a current ratio of 3.28 and a debt-to-equity ratio of 1.42. AAC has a 52 week low of $5.99 and a 52 week high of $13.06.

AAC (NYSE:AAC) last announced its quarterly earnings results on Wednesday, November 1st. The company reported $0.12 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.05 by $0.07. The company had revenue of $80.42 million during the quarter, compared to the consensus estimate of $74.49 million. AAC had a negative net margin of 0.42% and a positive return on equity of 9.64%. The company’s revenue for the quarter was up 14.0% compared to the same quarter last year. During the same period in the prior year, the business earned $0.19 earnings per share. sell-side analysts expect that AAC will post 0.54 earnings per share for the current fiscal year.

Several equities research analysts have weighed in on AAC shares. Cantor Fitzgerald restated a “buy” rating and set a $14.00 target price on shares of AAC in a research note on Thursday, November 16th. Zacks Investment Research cut AAC from a “hold” rating to a “sell” rating in a research note on Tuesday, October 3rd. UBS Group upgraded AAC from a “market perform” rating to an “outperform” rating in a research note on Friday, November 3rd. Finally, Raymond James Financial upgraded AAC from a “mkt perform” rating to an “outperform” rating in a research note on Friday, November 3rd. Two analysts have rated the stock with a hold rating and three have issued a buy rating to the company’s stock. The stock currently has an average rating of “Buy” and a consensus price target of $10.00.

In other news, Chairman Michael T. Cartwright sold 250,000 shares of the company’s stock in a transaction on Wednesday, November 15th. The shares were sold at an average price of $9.63, for a total transaction of $2,407,500.00. Following the completion of the transaction, the chairman now directly owns 2,880,490 shares in the company, valued at $27,739,118.70. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, major shareholder Jerrod N. Menz sold 700,000 shares of the company’s stock in a transaction on Tuesday, November 7th. The stock was sold at an average price of $10.22, for a total transaction of $7,154,000.00. The disclosure for this sale can be found here. 37.30% of the stock is currently owned by corporate insiders.

TRADEMARK VIOLATION NOTICE: “AAC (AAC) Getting Somewhat Positive News Coverage, Study Shows” was first published by Dispatch Tribunal and is owned by of Dispatch Tribunal. If you are accessing this piece on another domain, it was illegally stolen and reposted in violation of United States & international trademark & copyright laws. The original version of this piece can be accessed at https://www.dispatchtribunal.com/2018/01/13/aac-aac-getting-somewhat-positive-news-coverage-study-shows.html.

AAC Company Profile

AAC Holdings, Inc is a provider of inpatient and outpatient substance abuse treatment services for individuals with drug and alcohol addiction. The Company performs drug testing and diagnostics laboratory services and provides physician services to its clients. As of June 30, 2016, the Company operated 12 residential substance abuse treatment facilities located throughout the United States, focused on delivering clinical care and treatment solutions across 1,139 beds, which includes 636 licensed detoxification beds, and 18 standalone outpatient centers.

Insider Buying and Selling by Quarter for AAC (NYSE:AAC)

Receive News & Ratings for AAC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AAC and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply